New partnership connects researchers with global RWE/HEOR suppliers

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/everythingpossible)
(Image: Getty/everythingpossible)
The Scientist.com and HealthEconomics.com partnership connects real-world evidence (RWE) and health economic outcomes research (HEOR) sponsors and providers to help democratize pharmaceutical research, says company exec.

The online marketplace for outsourced research Scientist.com​ has partnered with HealthEconomics.com, which connects HEOR, RWE, and pharma market access to various stakeholder communities.

“This partnership is contributing to the rapid democratization of pharmaceutical research,”​ said Brian Bonnell, vice president of strategic partnerships, Scientist.com.

“Researchers can now use their laptop computer to access almost all the research services they need to run an entire drug research program, from concept to clinic,”​ he told us.

Drug researchers are increasingly using RWE to evaluate potential treatment benefits and risks, in addition to HEOR to analyze health care treatments from the patient and provider perspective, Bonnell explained.

“But, it is difficult and expensive for researchers to find RWE/HEOR suppliers and access critical data,”​ he added. “This partnership will make it easier for researchers to identify and evaluate the best RWE/HEOR suppliers for their needs, and to purchase the data and services they need to speed up value-based healthcare decisions.”

Bonnell said the new platform will address the many challenges facing RWE/HEOR researchers.

“It will enable them to connect with pre-qualified RWE/HEOR suppliers worldwide, evaluate multiple options and then easily purchase the data and services they need without time-consuming legal and finance review,”​ he added. “Both companies are contributing critical expertise to the project.”

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars